Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Daiichi Sankyo’s Turalio becomes first FDA-approved therapy for rare tumour

August 5, 2019 Sales and Marketing Cancer, Daiichi Sankyo, FDA, Turalio, US, pharma, rare cancer

Daiichi Sankyo has seen its CSF1R inhibitor Turalio (pexidartinib) approved by the FDA in the treatment of symptomatic tenosynovial giant …
News

Roche’s Tecentriq meets primary endpoint in Phase 3 bladder cancer trial

August 5, 2019 Sales and Marketing Cancer, Roche, bladder cancer, immunotherapy, oncology, tecentriq

Roche has said its immunotherapy drug Tecentriq (Atezolizumab), when used in combination with platinum-based chemotherapy, significantly reduced the risk of …
News

Dr Wajid Hussain appointed new clinical director for digital health at RCP

August 2, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IT, RCP, Royal College of Physicians, digital health, pharma

The Royal College of Physicians (RCP) has appointed Dr Wajid Hussain as its new clinical director for digital health. Dr …
Appointment

Top Ten most popular articles on Pharmafile.com this week!

August 2, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pfizer dominated the headlines this week as the US firm closed its $9.8 billion merger with GSK and announced that …
News

European approval for two new delivery formulations of GSK’s Nucala in severe eosinophilic asthma

August 2, 2019 Medical Communications, Sales and Marketing Europe, GSK, Nucala, asthma, pharma

Following closely on the heels of the news that its deal to merge Pfizer’s consumer health business with its own, …
News

Janssen returns rights for experimental cancer immunotherapy to Alligator Bioscience, sending shares spiraling by 40%

August 1, 2019 Sales and Marketing Alligator Bioscience, Janssen, pahrma

Janssen has decided to hand back the rights to an experimental CD40 agonistic antibody to Alligator Bioscience as it reassesses …
News

GSK closes the deal with Pfizer over $9.8 billion consumer healthcare merger

August 1, 2019 Sales and Marketing GSK, Pfizer, merger, pharma

The $9.8 billion joint venture between major pharma firms GlaxoSmithKline and Pfizer to merge their consumer health operations has come …
News

Bayer’s Xarelto combo greenlighted by NICE for reducing CV events in artery disease

August 1, 2019 Sales and Marketing NHS, NICE, UK, Xarelto, cardiovascular disease, pharma

NICE has awarded final appraisal recommendation to Bayer’s Xarelto (rivaroxaban) at a dosage of 2.5mg twice daily in combination with …
News

FDA steps up 2018 drug approvals by 11% on previous year

August 1, 2019 Sales and Marketing EMA, FDA, drug approvals, pharma

The FDA continues to excel in the ground it covers as it emerges that the total number of new drug …
News

Bayer and Orion’s Nubeqa secures FDA approval in non-metastatic castration-resistant prostate cancer

July 31, 2019 Research and Development, Sales and Marketing Bayer, Cancer, Nubeqa, orion, pharma, prostate cancer

The FDA has awarded approval under its Priority Review pathway to Nubeqa (darolutamide) for the treatment of non-metastatic castration-resistant prostate …
News

Bayer’s Vitravki poised to become first tumour-agnostic therapy in EU following CHMP recommendation

July 30, 2019 Manufacturing and Production, Sales and Marketing Bayer, CHMP, Cancer, EU, Vitrakvi, pharma

Bayer’s oral TRK inhibitor Vitrakvi (larotrectinib) could be set to become the European Union’s first drug approved in a tumour-agnostic …
News

The patient is always right: Extracting the full value of PROMs

July 29, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, PROs, UK, feature, patient reported outcomes, patient-reported outcomes, pharma

Patient-reported outcomes measures are an invaluable tool in ensuring that the patient remains in the driving seat when it comes …
Feature

Roche’s Tecentriq combo recommended in Europe for non-small cell lung cancer

July 29, 2019 Sales and Marketing Cancer, NSCLC, Roche, lung cancer, pharma, tecentriq

Riche’s blockbuster immunotherapy Tecentriq (atezolizumab) is closing in on securing yet another approval after it revealed that the drug was …
News

Sanofi ends partnership with Lexicon after release of Phase 3 data

July 29, 2019 Sales and Marketing Lexicon, Sanofi, Zynquista, diabetes, pharma

French firm Sanofi has said it is ending its partnership with Texas-based firm Lexicon Pharmaceuticals over the development of diabetes …
News

FDA issues warning to CBD company Curaleaf

July 29, 2019 Sales and Marketing CBD, FDA, cannabidiol, curaleaf, pharma, regulation

The FDA has issued a warning to Massachusetts-based CBD company Curaleaf over the firm’s use of unsubstantiated claims about the …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026